Global Systematic Scoping Review of Adolescent Factors Associated With COVID-19 Vaccine Hesitancy.

Brianna Agnew, Marie-Claude Couture, Honorine Uwimana, Timothy Callaghan, Elizabeth Jitka Olsanksa, Onyebuchi A Arah, Jillian Baker, Annette K Regan
Author Information
  1. Brianna Agnew: School of Nursing and Health Professions, University of San Francisco, San Francisco, California.
  2. Marie-Claude Couture: School of Nursing and Health Professions, University of San Francisco, San Francisco, California.
  3. Honorine Uwimana: School of Nursing and Health Professions, University of San Francisco, San Francisco, California.
  4. Timothy Callaghan: Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts.
  5. Elizabeth Jitka Olsanksa: School of Nursing and Health Professions, University of San Francisco, San Francisco, California.
  6. Onyebuchi A Arah: Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.
  7. Jillian Baker: Center for Teen Parent Communication, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania.
  8. Annette K Regan: School of Nursing and Health Professions, University of San Francisco, San Francisco, California; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California. Electronic address: annette.k.regan@kp.org.

Abstract

Although COVID-19 vaccination is recommended for adolescents aged 12-17 years, they remain one of the least commonly vaccinated age groups. Therefore, studies investigating the factors associated with vaccine hesitancy among adolescents are needed. We conducted a systematic review of the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards from inception to October 23, 2022, for adolescent-reported factors associated with vaccine hesitancy. Titles and abstracts of articles were screened, full-text articles were reviewed for eligibility, and eligible articles were extracted by 2 independent reviewers. Results were summarized using a narrative synthesis. The review protocol was prospectively registered in PROSPERO (CRD42022363411). Of 4,140 articles screened, 302 were selected for full-text review, 27 of which met the eligibility criteria. Most studies evaluated age (n = 20 studies) and sex (n = 21 studies) in relation to COVID-19 vaccine hesitancy, yet these were uncommonly linked with vaccine hesitancy among adolescents. Adolescents consistently reported the impact of the pandemic on social activities, social and parental norms, and a sense of communal responsibility as reasons for vaccinating. Although fewer studies (n = 18 studies) evaluated theoretical-based factors, the studies conducted showed that perceived vaccine safety and efficacy (n = 6 studies), risks from vaccination (n = 5 studies), and social and parental norms (n = 3) were consistently linked with vaccine hesitancy. To address low vaccination rates, adolescent-engaged research remains needed that considers their perspectives on COVID-19 vaccines.

Keywords

References

  1. Int J Environ Res Public Health. 2022 Apr 01;19(7): [PMID: 35409893]
  2. JAMA. 2024 Feb 6;331(5):408-416 [PMID: 38319331]
  3. N Engl J Med. 2022 Jan 13;386(2):e2 [PMID: 34965336]
  4. Front Med (Lausanne). 2021 Jul 07;8:691079 [PMID: 34307416]
  5. J Korean Med Sci. 2021 Aug 09;36(31):e227 [PMID: 34402237]
  6. BMC Public Health. 2023 Apr 28;23(1):784 [PMID: 37118794]
  7. Sci Rep. 2022 Jun 23;12(1):9950 [PMID: 35739136]
  8. Pediatrics. 2018 Nov;142(Suppl 3):S142-S148 [PMID: 30385620]
  9. N Engl J Med. 2021 Jul 15;385(3):239-250 [PMID: 34043894]
  10. Disaster Med Public Health Prep. 2022 Jul 27;17:e201 [PMID: 35882387]
  11. J Adolesc Health. 2021 Dec;69(6):910-916 [PMID: 34666957]
  12. Vaccines (Basel). 2020 Jun 05;8(2): [PMID: 32516936]
  13. Vaccines (Basel). 2022 Apr 29;10(5): [PMID: 35632453]
  14. Vaccine. 2022 Dec 5;40(51):7466-7475 [PMID: 34742594]
  15. Patient Educ Couns. 2024 Jan;118:108007 [PMID: 37847989]
  16. Vaccines (Basel). 2022 Jul 08;10(7): [PMID: 35891264]
  17. Am J Perinatol. 2022 Jan;39(1):75-83 [PMID: 34598291]
  18. Front Public Health. 2022 May 12;10:877668 [PMID: 35646783]
  19. J Adolesc Health. 2022 Sep;71(3):277-284 [PMID: 35988951]
  20. JAMA Netw Open. 2023 May 1;6(5):e2311957 [PMID: 37145598]
  21. Eur Child Adolesc Psychiatry. 2023 Mar;32(3):537-539 [PMID: 34550459]
  22. Hum Vaccin Immunother. 2021 Dec 2;17(12):5013-5015 [PMID: 34715003]
  23. Fam Syst Health. 2009 Sep;27(3):249-66 [PMID: 19803619]
  24. EClinicalMedicine. 2020 Sep;26:100495 [PMID: 32838242]
  25. Int J Environ Res Public Health. 2022 Jan 18;19(3): [PMID: 35162076]
  26. J Res Adolesc. 2021 Sep;31(3):486-499 [PMID: 34448306]
  27. PLOS Glob Public Health. 2022 Oct 5;2(10):e0000611 [PMID: 36962540]
  28. PLoS One. 2018 Dec 7;13(12):e0208601 [PMID: 30532274]
  29. J Adolesc Health. 2019 May;64(5):622-630 [PMID: 30655120]
  30. J Multidiscip Healthc. 2022 Oct 14;15:2341-2352 [PMID: 36267849]
  31. Neuron. 2010 Sep 9;67(5):749-60 [PMID: 20826307]
  32. JAMA Health Forum. 2021 Aug 20;2(8):e212103 [PMID: 35977195]
  33. PLOS Glob Public Health. 2023 Nov 10;3(11):e0002493 [PMID: 37948353]
  34. Front Public Health. 2021 Aug 13;9:698111 [PMID: 34485229]
  35. BMJ. 2022 Nov 30;379:e073070 [PMID: 36450402]
  36. Med Decis Making. 2015 Apr;35(3):403-8 [PMID: 25145576]
  37. Int J Environ Res Public Health. 2020 Jul 10;17(14): [PMID: 32664369]
  38. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  39. Healthcare (Basel). 2022 Jan 18;10(2): [PMID: 35206799]
  40. Vaccine. 2014 Aug 6;32(36):4602-13 [PMID: 24996123]
  41. Eur J Pediatr. 2022 Apr;181(4):1757-1762 [PMID: 34935085]
  42. Vaccine. 2022 Feb 11;40(7):967-969 [PMID: 35063284]
  43. MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1206-1213 [PMID: 34473680]
  44. Ethn Health. 2014 Feb;19(1):47-63 [PMID: 24261842]
  45. Rev Assoc Med Bras (1992). 2021 Sep;67(9):1333-1337 [PMID: 34816930]
  46. Int J Biol Sci. 2022 Jan 31;18(4):1627-1650 [PMID: 35280678]
  47. Vaccine. 2021 Jun 11;39(26):3473-3479 [PMID: 34023134]
  48. J Adolesc Health. 2022 Aug;71(2):164-171 [PMID: 35718652]
  49. MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):997-1003 [PMID: 34264908]
  50. Aust N Z J Obstet Gynaecol. 2015 Apr;55(2):131-7 [PMID: 25557858]
  51. MMWR Morb Mortal Wkly Rep. 2024 Apr 11;73(14):307-311 [PMID: 38602879]
  52. PLoS One. 2021 Mar 10;16(3):e0242587 [PMID: 33690600]
  53. Vaccine. 2021 Sep 24;39(40):5741-5747 [PMID: 34483023]
  54. Front Public Health. 2024 Apr 10;12:1338208 [PMID: 38660347]
  55. Public Health. 2022 Jun;207:39-45 [PMID: 35486982]
  56. Rev Paul Pediatr. 2019 Jun 19;37(4):503-509 [PMID: 31241694]
  57. Vaccine. 2022 Feb 7;40(6):833-836 [PMID: 35042646]
  58. EClinicalMedicine. 2021 Oct;40:101144 [PMID: 34608453]
  59. Psychol Sci Public Interest. 2017 Dec;18(3):149-207 [PMID: 29611455]
  60. Vaccines (Basel). 2022 Mar 15;10(3): [PMID: 35335083]
  61. Vaccines (Basel). 2021 Dec 21;10(1): [PMID: 35062665]
  62. MMWR Morb Mortal Wkly Rep. 2023 Feb 17;72(7):190-198 [PMID: 36795677]
  63. J Pediatr Psychol. 2012 Apr;37(3):292-306 [PMID: 22138318]
  64. Prev Med Rep. 2022 Sep 07;29:101977 [PMID: 36090471]
  65. MMWR Morb Mortal Wkly Rep. 2024 Apr 18;73(15):330-338 [PMID: 38635481]
  66. Int J Environ Res Public Health. 2022 Jun 27;19(13): [PMID: 35805530]
  67. Vaccine X. 2021 Dec;9:100117 [PMID: 34693273]
  68. PLOS Glob Public Health. 2023 Sep 20;3(9):e0002385 [PMID: 37729153]
  69. Vaccine. 2016 Feb 17;34(8):1018-24 [PMID: 26672676]
  70. Nat Hum Behav. 2022 Dec;6(12):1609-1610 [PMID: 36418535]
  71. BMJ Open. 2021 Jun 15;11(6):e048172 [PMID: 34130963]
  72. BMC Public Health. 2012 Jul 07;12:509 [PMID: 22768870]
  73. J Psychiatr Res. 2022 Aug;152:25-30 [PMID: 35714550]

Grants

  1. L40 AI178819/NIAID NIH HHS
  2. R21 HD109536/NICHD NIH HHS

MeSH Term

Humans
Adolescent
COVID-19 Vaccines
Vaccination Hesitancy
COVID-19
Male
Female
SARS-CoV-2
Child

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0studiesvaccinen =COVID-19hesitancyvaccinationarticlesadolescentsfactorsreviewsocialAdolescentAlthoughageassociatedamongneededconductedSystematicscreenedfull-texteligibilityevaluatedlinkedconsistentlyparentalnormsVaccinerecommendedaged12-17 yearsremainoneleastcommonlyvaccinatedgroupsThereforeinvestigatingsystematicliteratureaccordancePreferredReportingItemsReviewsMeta-AnalysesstandardsinceptionOctober232022adolescent-reportedTitlesabstractsreviewedeligibleextracted2independentreviewersResultssummarizedusingnarrativesynthesisprotocolprospectivelyregisteredPROSPEROCRD420223634114140302selected27metcriteria20sex21relationyetuncommonlyAdolescentsreportedimpactpandemicactivitiessensecommunalresponsibilityreasonsvaccinatingfewer18theoretical-basedshowedperceivedsafetyefficacy6risks53addresslowratesadolescent-engagedresearchremainsconsidersperspectivesvaccinesGlobalScopingReviewFactorsAssociatedHesitancyhealthdecision-making

Similar Articles

Cited By (1)